A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension



Status:Completed
Conditions:High Blood Pressure (Hypertension), Ocular
Therapuetic Areas:Cardiology / Vascular Diseases, Ophthalmology
Healthy:No
Age Range:18 - Any
Updated:5/5/2014
Start Date:July 2013
End Date:September 2014
Contact:Allergan Inc.
Email:clinicaltrials@allergan.com

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

This safety study will evaluate bimatoprost 0.01% and 0.03% in patients with glaucoma or
ocular hypertension (OHT).


Inclusion Criteria:

- Diagnosis of glaucoma or ocular hypertension

Exclusion Criteria:

- Active ocular disease other than glaucoma or ocular hypertension

- Require chronic use of ocular medications other than the study medication during the
study (intermittent use of artificial tear solution will be permitted)
We found this trial at
2
sites
Clinical Trial Facility in El Paso Texas
El Paso, Texas 79902
?
mi
from
El Paso, TX
Click here to add this to my saved trials
Clinical Trial Facility in Artesia California
Artesia, California 90701
?
mi
from
Artesia, CA
Click here to add this to my saved trials